Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression

Journal of Neurology

Volumn 262, Issue 7, 2015, Pages 1665-1672

  Vilas, Dolores ^a   Iranzo, Alex ^a   Pont Sunyer, Claustre ^a   Serradell, Mónica ^a   Gaig, Carles ^a   Santamaria, Joan ^a   Tolosa, Eduardo ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Brainstem raphe; Parkinson disease; REM sleep behavior disorder; Substantia nigra; Transcranial sonography

Indexed keywords

CLONAZEPAM; MELATONIN;

ADJUSTMENT DISORDER; AGED; ARTICLE; BRAIN STEM; BRAINSTEM RAPHE; COMORBID DEPRESSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; DORSAL RAPHE NUCLEUS; DSM-IV; ECHOGENICITY; ECHOGRAPHY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MIDBRAIN RAPHE NUCLEUS; NERVOUS SYSTEM PARAMETERS; PARASOMNIA; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; SYMPTOMATOLOGY; TRANSCRANIAL SONOGRAPHY; ULTRASOUND TRANSDUCER; UNIFIED PARKINSON DISEASE RATING SCALE; UPDRS III; CASE CONTROL STUDY; COMORBIDITY; PATHOLOGY; RAPHE NUCLEUS; REM SLEEP BEHAVIOR DISORDER; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY;

AGED; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; MALE; RAPHE NUCLEI; REM SLEEP BEHAVIOR DISORDER; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84937966215     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7745-0     Document Type: Article

References (32)

1. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
2. Tolosa E, Pont-Sunyer C (2011) Progress in defining the premotor phase of Parkinson’s disease. J Neurol Sci 310:4–8
3. Postuma RB, Aarslnad D, Barone P et al (2012) Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease. Mov Disord 27:617–626
4. Plomhouse L, Dujarin K, Duhamel A et al (2013) Rapid eye movement sleep behaviour disorder in treatment-naïve Parkinson disease patients. Sleep Med 14:1035–1037
5. Iranzo A, Santamaria J, Rye DB et al (2005) Characteristics of idiopathic REM sleep behaviour disorder and that associated with MSA and PD. Neurology 65:247–252
6. Pont-Sunyer C, Hotter A, Gaig C et al (2015) The onset of nonmotor symptoms in Parkinson’s disease (The ONSET PD Study). Mov Disord 30:229–237
7. Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748
8. Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M et al (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453
9. Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behaviour disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767
10. Nilsson FM, Kessing LV, Bolwig TC (2001) Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104:380–386
11. Leentjens AFG, Van den Akker M, Metsemakers JFM, Lousberg R, Verhey FRJ (2003) Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 18:414–418
12. Santamaria J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36:1130–1133
13. Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson disease. Mov Disord 24:1641–1649
14. Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044–1055
15. Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P et al (2013) Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson’s disease. Mov Disord 28:216–219
16. Iranzo A, Stockner H, Serradell M, Seppi K, Valldeoriola F, Frauscher B et al (2014) Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behaviour disorder. Mov Disord 29:1774–1780
17. Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R (2007) Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130:1799–1807
18. Becker G, Struck M, Bogdahn U, Becker T (1994) Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 55:75–84
19. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M et al (1997) Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63:590–596
20. Berg D, Supprian T, Hofmann E, Zeiler B, Jager A, Lange KW et al (1999) Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 246:1186–1193
21. Cho JW, Baik JS, Lee MS (2011) Mesencephalic midline change on transcranial sonography in early Parkinson disease patients with depression. J Neurol Sci 310:50–52
22. Schmidauer C, Sojer M, Seppi K et al (2005) Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 58:630–634
23. American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
24. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement disorder society-sponsored revision of the unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170
25. American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders 4a. American Psychiatric Association, Washington, DC
26. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
27. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
28. Schrag A, Hosrdfall L, Walters K, Noyce A, Petersen I (2014) Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol 14:57–64
29. Kessler RC, Birnbaum H, Bromet E et al (2010) Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psaychol Med 40:225–237
30. Richards D (2011) Prevalence and clinical course of depression: a review. Clin Psycol Rev 31:117–1125
31. Grinberg LT, Rueb U, di Lorenzo AT, Heinsen H (2010) Brainstem pathology and non-motor symptoms of PD. J Neurol Sci 289:81–88
32. Walter U, Skoloduik D, Berg D (2010) Transcranial sonography findings related to non-motor features of Parkinson’s disease. J Neurol Sci 289:123–127